BOSULIF vs PHYRAGO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. BOSULIF and PHYRAGO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BOSULIF	PHYRAGO
Rating	New	New
Pharmacy pays	—	~$839.19 /30
Type	RX	RX
Active ingredient	BOSUTINIB MONOHYDRATE	DASATINIB
Manufacturer	Pf Prism Cv	Handa Therap
Dosage forms	Capsule, Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Bcr-Abl Positive Chronic Myelogenous Leukemia	Lymphoid Leukemia, Myeloid Leukemia

bosulif phyrago

Rating

New

Pharmacy pays

—

~$839.19 /30

Type

Active ingredient

BOSUTINIB MONOHYDRATE

DASATINIB

Manufacturer

Pf Prism Cv

Handa Therap

Dosage forms

Capsule, Tablet

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Bcr-Abl Positive Chronic Myelogenous Leukemia

Lymphoid Leukemia, Myeloid Leukemia

Frequently asked questions

What is the difference between Bosulif and Phyrago?

Bosulif contains Bosutinib Monohydrate, while Phyrago contains Dasatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.